Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Post by ART535455on Feb 03, 2021 8:46pm
121 Views
Post# 32466658

MODERATE BUY

MODERATE BUY

THC Biomed INTL Ltd(THCBF)

OTHER OTC:THCBF

$0.12
$0.007
(5.367%)
At close: Feb 03 4:00PM EST
89Followers

 THC Biomed INTL Stock Forecast & Price Targets

Showing:

Analyst Rating Consensus

Moderate Buy

Based on 1 Analyst Ratings


  • 1 Buy
  • 0 Hold
  • 0 Sell

Based on 1 Wall Street analysts offering stock ratings for THC Biomed INTL in the last 3 months (by analysts ranked 0 to 5 stars).

Analyst Price Target on THCBF

$0.22
 (72.14% Upside)

Based on 1 analyst offering 12 month price targets for THC Biomed INTL in the last 3 months. The average price target is $0.22 with a high forecast of $0.22 and a low forecast of $0.22. The average price target represents a 72.14% increase from the last price of $0.12.

Past 12 Months     12 Months ForecastFeb2020MayAugNovFeb202100.250.500.751Feb2022
 
Average
$0.22
Low
$0.22
High
$0.22

Detailed list of analyst forecasts


<< Previous
Bullboard Posts
Next >>